AAAAAA

   
Results: 1-11 |
Results: 11
Glycopeptide-intermediate Staphylococcus aureus: rediscovery of an old problem? (vol 6, pg 517, 2000)
Authors: Cercenado, E
Citation: E. Cercenado, Glycopeptide-intermediate Staphylococcus aureus: rediscovery of an old problem? (vol 6, pg 517, 2000), CL MICRO IN, 7(3), 2001, pp. 170-170
Comparative in vitro activity of the new quinolone gemifloxacin (SB-265805) with other fluoroquinolones against respiratory tract pathogens
Authors: Garcia-Garrote, F Cercenado, E Martin-Pedroviejo, J Cuevas, O Bouza, E
Citation: F. Garcia-garrote et al., Comparative in vitro activity of the new quinolone gemifloxacin (SB-265805) with other fluoroquinolones against respiratory tract pathogens, J ANTIMICRO, 47(5), 2001, pp. 681-684
In vitro activity of linezolid against multiply resistant Gram-positive clinical isolates
Authors: Cercenado, E Garcia-Garrote, F Bouza, E
Citation: E. Cercenado et al., In vitro activity of linezolid against multiply resistant Gram-positive clinical isolates, J ANTIMICRO, 47(1), 2001, pp. 77-81
Glycopeptide-intermediate Staphylococcus aureus: rediscovery of an old problem?
Authors: Cercenado, E
Citation: E. Cercenado, Glycopeptide-intermediate Staphylococcus aureus: rediscovery of an old problem?, CL MICRO IN, 6(10), 2000, pp. 517-518
Evidence of nosocomial Stenotrophomonas maltophilia cross-infection in a neonatology unit analyzed by three molecular typing methods - The authors reply
Authors: de Viedma, DG Marin, M Cercenado, E Alonso, R Creixems, MR Bouza, E
Citation: Dg. De Viedma et al., Evidence of nosocomial Stenotrophomonas maltophilia cross-infection in a neonatology unit analyzed by three molecular typing methods - The authors reply, INFECT CONT, 21(7), 2000, pp. 433-434
Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci
Authors: Garcia-Garrote, F Cercenado, E Bouza, E
Citation: F. Garcia-garrote et al., Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci, J CLIN MICR, 38(6), 2000, pp. 2108-2111
Heterogeneous antimicrobial resistance patterns in polyclonal populations of coagulase-negative staphylococci isolated from catheters
Authors: de Viedma, DG Rabadan, PM Diaz, M Cercenado, E Bouza, E
Citation: Dg. De Viedma et al., Heterogeneous antimicrobial resistance patterns in polyclonal populations of coagulase-negative staphylococci isolated from catheters, J CLIN MICR, 38(4), 2000, pp. 1359-1363
Evidence of nosocomial Stenothrophomonas maltophilia cross-infection in a neonatology unit analyzed by three molecular typing methods
Authors: de Viedma, DG Marin, M Cercenado, E Alonso, R Rodriguez-Creixems, M Bouza, E
Citation: Dg. De Viedma et al., Evidence of nosocomial Stenothrophomonas maltophilia cross-infection in a neonatology unit analyzed by three molecular typing methods, INFECT CONT, 20(12), 1999, pp. 816-820
In vitro activity of the new quinolone moxifloxacin (Bay 12-8039) against resistant gram-positive clinical isolates
Authors: Alcala, L Cercenado, E Garcia-Garrote, F Bouza, E
Citation: L. Alcala et al., In vitro activity of the new quinolone moxifloxacin (Bay 12-8039) against resistant gram-positive clinical isolates, DIAG MICR I, 33(1), 1999, pp. 27-31
Cytopathic effect inhibition assay for determining the in-vitro susceptibility of herpes simplex virus to antiviral agents
Authors: Cotarelo, M Catalan, P Sanchez-Carrillo, C Menasalvas, A Cercenado, E Tenorio, A Bouza, E
Citation: M. Cotarelo et al., Cytopathic effect inhibition assay for determining the in-vitro susceptibility of herpes simplex virus to antiviral agents, J ANTIMICRO, 44(5), 1999, pp. 705-708
Pseudomonas aeruginosa: a survey of resistance in 136 hospitals in Spain
Authors: Bouza, E Garcia-Garrote, F Cercenado, E Marin, M Diaz, MS
Citation: E. Bouza et al., Pseudomonas aeruginosa: a survey of resistance in 136 hospitals in Spain, ANTIM AG CH, 43(4), 1999, pp. 981-982
Risultati: 1-11 |